In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, discusses the real-world use of aflibercept 8 mg in wet age-related macular degeneration or diabetic macular edema.

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...

Get a sneak peek of this episode where Pete is literally trying to give money away to anyone who can pull off the simple task ...

Get a sneak peek and see what happens when Pete takes a board he’s never ridden before into a concrete drainage ditch. See ...

Outlook Therapeutics (OTLK) stock rises as the company's wet AMD therapy ONS-5010 undergoes FDA review, with a decision ...

Lutein and zeaxanthin are two nutrients that come from colorful fruits and vegetables, especially leafy greens like spinach ...

A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.

Carrots are rich in antioxidants that support night vision, reduce the risk of age-related vision loss, and protect against ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

However, scientists at Stanford University are giving new hope to people with this condition. Led by Professor Daniel ...